Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment
source: pixabay.com

Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment

According to a story from prnewswire.com, the biopharmaceutical company Dompé recently announced that the company has received the 2019 Industry Innovation Award from the National Organization of Rare Disorders (NORD).…

Continue Reading Company Receives Award for Developing Breakthrough Neurotrophic Keratitis Treatment
New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease
source: pixabay.com

New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease

According to a story from news-medical.net, a recent study has reshaped the scientific understanding of the origins of mitochondrial disease. For decades any mutation that affected the mitochondrial DNA and…

Continue Reading New Discovery Adds Greater Complexity to the Genetic Basis of Mitochondrial Disease

Biotech Companies are Increasingly Focused on Deadly Diseases With Significant Unmet Need

According to a story from finanznachrichten.de, biotechnology companies are starting to set their sights on treating deadly diseases that are lacking effective treatment options, including some diseases that are considered…

Continue Reading Biotech Companies are Increasingly Focused on Deadly Diseases With Significant Unmet Need

Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient

Phase 1 Trial A Phase 1 trial by Gamida Cell is examining a new potential treatment option for patients with multiple myeloma and relapsed/refractory non-Hodgkin's lymphoma who have not responded…

Continue Reading Preliminary Data from Phase 1 Trial for Multiple Myeloma Indicates Complete Response in a Patient
Close Menu